Regulation of the interferon-inducible 2′-5′-oligoadenylate synthetases by adenovirus VAI RNA

Journal of Molecular Biology

Volumn 422, Issue 5, 2012, Pages 635-649

  Meng, Hui ^a   Deo, Soumya ^a   Xiong, Shawn ^a   Dzananovic, Edis ^a   Donald, Lynda J ^a   Van Dijk, Cody W ^a   McKenna, Sean A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

adenovirus; double stranded RNA; innate immune response; oligoadenylate synthetase

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; INTERFERON; VIRUS RNA;

ADENOVIRUS; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME ASSAY; ENZYME INHIBITION; GEL MOBILITY SHIFT ASSAY; INHIBITION KINETICS; INNATE IMMUNITY; LIGHT SCATTERING; MASS SPECTROMETRY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; REGULATORY MECHANISM; RNA TRANSCRIPTION; STOICHIOMETRY;

ADENOVIRIDAE;

EID: 84865675957     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2012.06.017     Document Type: Article

References (57)

1. A.J. Karpala, T.J. Doran, and A.G. Bean Immune responses to dsRNA: implications for gene silencing technologies Immunol. Cell Biol. 83 2005 211 216
2. L. Malmgaard Induction and regulation of IFNs during viral infections J. Interferon Cytokine Res. 24 2004 439 454
3. A.J. Sadler, and B.R. Williams Interferon-inducible antiviral effectors Nat. Rev., Immunol. 8 2008 559 568
4. A.G. Hovanessian, and J. Justesen The human 2′- 5′oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation Biochimie 89 2007 779 788
5. M.R. Player, and P.F. Torrence The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation Pharmacol. Ther. 78 1998 55 113
6. nA) in interferon-treated cells Nucleic Acids Res. 9 1981 1571 1581
7. R.K. Maitra, N.A. McMillan, S. Desai, J. McSwiggen, A.G. Hovanessian, and G. Sen HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes Virology 204 1994 823 827
8. T.V. Sharp, D.A. Raine, D.R. Gewert, B. Joshi, R. Jagus, and M.J. Clemens Activation of the interferon-inducible (2′-5′) oligoadenylate synthetase by the Epstein-Barr virus RNA, EBER-1 Virology 257 1999 303 313
9. E. Mordechai, N. Kon, E.E. Henderson, and R.J. Suhadolnik Activation of the interferon-inducible enzymes, 2′,5′-oligoadenylate synthetase and PKR by human T-cell leukemia virus type I Rex-response element Virology 206 1995 913 922
10. S. Kakuta, S. Shibata, and Y. Iwakura Genomic structure of the mouse 2′,5′-oligoadenylate synthetase gene family J. Interferon Cytokine Res. 22 2002 981 993
11. A.A. Perelygin, A.A. Zharkikh, S.V. Scherbik, and M.A. Brinton The mammalian 2′-5′ oligoadenylate synthetase gene family: evidence for concerted evolution of paralogous Oas1 genes in Rodentia and Artiodactyla J. Mol. Evol. 63 2006 562 576
12. R. Hartmann, J. Justesen, S.N. Sarkar, G.C. Sen, and V.C. Yee Crystal structure of the 2′-specific and double-stranded RNA-activated interferon-induced antiviral protein 2′-5′-oligoadenylate synthetase Mol. Cell 12 2003 1173 1185
13. S.N. Sarkar, S. Pal, and G.C. Sen Crisscross enzymatic reaction between the two molecules in the active dimeric P69 form of the 2′-5′ oligodenylate synthetase J. Biol. Chem. 277 2002 44760 44764
14. S. Torralba, J. Sojat, and R. Hartmann 2′-5′ Oligoadenylate synthetase shares active site architecture with the archaeal CCA-adding enzyme Cell. Mol. Life Sci. 65 2008 2613 2620
15. S.Y. Desai, and G.C. Sen Effects of varying lengths of double-stranded RNA on binding and activation of 2′-5′-oligoadenylate synthetase J. Interferon Cytokine Res. 17 1997 531 536
16. R. Kodym, E. Kodym, and M.D. Story 2′-5′-Oligoadenylate synthetase is activated by a specific RNA sequence motif Biochem. Biophys. Res. Commun. 388 2009 317 322
17. M.A. Minks, D.K. West, S. Benvin, and C. Baglioni Structural requirements of double-stranded RNA for the activation of 2′,5′-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells J. Biol. Chem. 254 1979 10180 10183
18. B.R. Anderson, H. Muramatsu, B.K. Jha, R.H. Silverman, D. Weissman, and K. Kariko Nucleoside modifications in RNA limit activation of 2′-5′-oligoadenylate synthetase and increase resistance to cleavage by RNase L Nucleic Acids Res. 39 2011 9329 9338
19. R. Hartmann, P.L. Norby, P.M. Martensen, P. Jorgensen, M.C. James, and C. Jacobsen Activation of 2′-5′ oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers J. Biol. Chem. 273 1998 3236 3246
20. S.R. Nallagatla, R. Toroney, and P.C. Bevilacqua A brilliant disguise for self RNA: 5′-end and internal modifications of primary transcripts suppress elements of innate immunity RNA Biol. 5 2008 140 144
21. S.R. Nallagatla, J. Hwang, R. Toroney, X. Zheng, C.E. Cameron, and P.C. Bevilacqua 5′-Triphosphate-dependent activation of PKR by RNAs with short stem-loops Science 318 2007 1455 1458
22. B. Thimmappaya, C. Weinberger, R.J. Schneider, and T. Shenk Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection Cell 31 1982 543 551
23. M.B. Mathews, and T. Shenk Adenovirus virus-associated RNA and translation control J. Virol. 65 1991 5657 5662
24. M.B. Mathews Structure, function, and evolution of adenovirus virus-associated RNAs Curr. Top. Microbiol. Immunol. 199 1995 173 187
25. P.A. Clarke, T. Pe'ery, Y. Ma, and M.B. Mathews Structural features of adenovirus 2 virus-associated RNA required for binding to the protein kinase DAI Nucleic Acids Res. 22 1994 4364 4374
26. K.H. Mellits, and M.B. Mathews Effects of mutations in stem and loop regions on the structure and function of adenovirus VA RNAI EMBO J. 7 1988 2849 2859
27. J. Kitajewski, R.J. Schneider, B. Safer, S.M. Munemitsu, C.E. Samuel, B. Thimmappaya, and T. Shenk Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2α kinase Cell 45 1986 195 200
28. R.P. O'Malley, T.M. Mariano, J. Siekierka, and M.B. Mathews A mechanism for the control of protein synthesis by adenovirus VA RNAI Cell 44 1986 391 400
29. M. Gale Jr, and M.G. Katze Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase Pharmacol. Ther. 78 1998 29 46
30. G.D. Ghadge, P. Malhotra, M.R. Furtado, R. Dhar, and B. Thimmapaya In vitro analysis of virus-associated RNA I (VAI RNA): inhibition of the double-stranded RNA-activated protein kinase PKR by VAI RNA mutants correlates with the in vivo phenotype and the structural integrity of the central domain J. Virol. 68 1994 4137 4151
31. S.A. McKenna, D.A. Lindhout, T. Shimoike, C.E. Aitken, and J.D. Puglisi Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR J. Mol. Biol. 372 2007 103 113
32. M.R. Furtado, S. Subramanian, R.A. Bhat, D.M. Fowlkes, B. Safer, and B. Thimmappaya Functional dissection of adenovirus VAI RNA J. Virol. 63 1989 3423 3434
33. P.A. Clarke, and M.B. Mathews Interactions between the double-stranded RNA binding motif and RNA: definition of the binding site for the interferon-induced protein kinase DAI (PKR) on adenovirus VA RNA RNA 1 1995 7 20
34. S.A. McKenna, I. Kim, C.W. Liu, and J.D. Puglisi Uncoupling of RNA binding and PKR kinase activation by viral inhibitor RNAs J. Mol. Biol. 358 2006 1270 1285
35. A.M. Wahid, V.K. Coventry, and G.L. Conn Systematic deletion of the adenovirus-associated RNAI terminal stem reveals a surprisingly active RNA inhibitor of double-stranded RNA-activated protein kinase J. Biol. Chem. 283 2008 17485 17493
36. M.G. Andersson, P.C. Haasnoot, N. Xu, S. Berenjian, B. Berkhout, and G. Akusjarvi Suppression of RNA interference by adenovirus virus-associated RNA J. Virol. 79 2005 9556 9565
37. S. Lu, and B.R. Cullen Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and microRNA biogenesis J. Virol. 78 2004 12868 12876
38. N. Xu, S. Gkountela, K. Saeed, and G. Akusjarvi The 5′-end heterogeneity of adenovirus virus-associated RNAI contributes to the asymmetric guide strand incorporation into the RNA-induced silencing complex Nucleic Acids Res. 37 2009 6950 6959
39. N. Xu, B. Segerman, X. Zhou, and G. Akusjarvi Adenovirus virus-associated RNAII-derived small RNAs are efficiently incorporated into the RNA-induced silencing complex and associate with polyribosomes J. Virol. 81 2007 10540 10549
40. S.Y. Desai, R.C. Patel, G.C. Sen, P. Malhotra, G.D. Ghadge, and B. Thimmapaya Activation of interferon-inducible 2′-5′ oligoadenylate synthetase by adenoviral VAI RNA J. Biol. Chem. 270 1995 3454 3461
41. T.V. Sharp, M. Schwemmle, I. Jeffrey, K. Laing, H. Mellor, and C.G. Proud Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA Nucleic Acids Res. 21 1993 4483 4490
42. A. Ghosh, S.N. Sarkar, W. Guo, S. Bandyopadhyay, and G.C. Sen Enzymatic activity of 2′-5′-oligoadenylate synthetase is impaired by specific mutations that affect oligomerization of the protein J. Biol. Chem. 272 1997 33220 33226
43. D. Rebouillat, and A.G. Hovanessian The human 2′,5′- oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties J. Interferon Cytokine Res. 19 1999 295 308
44. R. Hartmann, G. Walko, and J. Justesen Inhibition of 2′-5′ oligoadenylate synthetase by divalent metal ions FEBS Lett. 507 2001 54 58
45. N. Potier, L.J. Donald, I. Chernushevich, A. Ayed, W. Ens, and C.H. Arrowsmith Study of a noncovalent trp repressor: DNA operator complex by electrospray ionization time-of-flight mass spectrometry Protein Sci. 7 1998 1388 1395
46. L.J. Donald, D.J. Hosfield, S.L. Cuvelier, W. Ens, K.G. Standing, and H.W. Duckworth Mass spectrometric study of the Escherichia coli repressor proteins, Ic1R and Gc1R, and their complexes with DNA Protein Sci. 10 2001 1370 1380
47. Y. Ma, and M.B. Mathews Comparative analysis of the structure and function of adenovirus virus-associated RNAs J. Virol. 67 1993 6605 6617
48. S.A. McKenna, D.A. Lindhout, T. Shimoike, and J.D. Puglisi Biophysical and biochemical investigations of dsRNA-activated kinase PKR Methods Enzymol. 430 2007 373 396
49. S.A. McKenna, I. Kim, E.V. Puglisi, D.A. Lindhout, C.E. Aitken, R.A. Marshall, and J.D. Puglisi Purification and characterization of transcribed RNAs using gel filtration chromatography Nat. Protoc. 2 2007 3270 3277
50. S.P. Ryder, M.I. Recht, and J.R. Williamson Quantitative analysis of protein-RNA interactions by gel mobility shift Methods Mol. Biol. 488 2008 99 115
51. A. Shevchenko, H. Tomas, J. Havlis, J.V. Olsen, and M. Mann In-gel digestion for mass spectrometric characterization of proteins and proteomes Nat. Protoc. 1 2006 2856 2860
52. A.V. Loboda, A.N. Krutchinsky, M. Bromirski, W. Ens, and K.G. Standing A tandem quadrupole/time-of-flight mass spectrometer with a matrix-assisted laser desorption/ionization source: design and performance Rapid Commun. Mass Spectrom. 14 2000 1047 1057
53. A. Shevchenko, A. Loboda, A. Shevchenko, W. Ens, and K.G. Standing MALDI quadrupole time-of-flight mass spectrometry: a powerful tool for proteomic research Anal. Chem. 72 2000 2132 2141
54. L.J. Donald, H.W. Duckworth, and K.G. Standing Mass spectrometry in noncovalent protein interactions and protein assemblies J. Celis, Cell Biology: A Laboratory Handbook 3rd ed. 2006 Elsevier Science Inc. San Diego, CA 457 464
55. V.I. Kozlovski, L.J. Donald, V.M. Collado, V. Spicer, A.V. Loboda, and I.V. Chernushevich A TOF mass spectrometer for the study of noncovalent complexes Int. J. Mass Spectrom. 308 2011 118 125
56. R.F. Putnins, and E.W. Yamada Colorimetric determination of inorganic pyrophosphate by a manual or automated method Anal. Biochem. 68 1975 185 195
57. J. Justesen, and N.O. Kjeldgaard Spectrophotometric pyrophosphate assay of 2′,5′-oligoadenylate synthetase Anal. Biochem. 207 1992 90 93